Insulin lispro mix 25/75 twice daily (LM25) vs basal insulin glargine once daily and prandial insulin lispro once daily (BP) in type 2 diabetes: insulin intensification

被引：0
|
作者：
Tinahones, F. J. [1 ]
Gross, J. L. [2 ]
Onaca, A.
Zhou, Z. [3 ,4 ]
Cleall, S. [5 ]
Rodriguez, A. [6 ]
机构：
[1] Hosp Univ Virgen de la Victoria, Malaga, Spain
[2] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[3] Second Xiangya Hosp, Ctr Diabet, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China
[4] Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China
[5] Eli Lilly & Co, Windlesham, Surrey, England
[6] Lilly Spain, Alcobendas, Spain
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1025
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [41] Comparison of insulin lispro mixed with NPH or ultralente insulin twice daily in type 1 patients
    Reviriego, J
    Bolanos, E
    [J]. DIABETES, 1998, 47 : A103 - A103
  • [42] Treatment Intensification by Stepwise Addition of Prandial Insulin Aspart to Once-Daily Basal Insulin Detemir in Subjects with Type 2 Diabetes: The STEPwise™ Trial
    Meneghini, Luigi F.
    Hermansen, Kjeld
    Mersebach, Henriette
    Svendsen, Anne Louise
    Kumar, Sudhesh
    [J]. DIABETES, 2010, 59 : A199 - A199
  • [43] Efficacy of switching from premix analog insulin twice daily injection to insulin glargine once daily injection with sitagliptin
    Takahashi H.
    Sakai K.
    Kawanishi K.
    Suzuki J.
    Igawa K.
    Sankoda K.
    Noto T.
    Nagasaka Y.
    [J]. Diabetology International, 2015, 6 (1) : 33 - 38
  • [44] Technosphere® Insulin vs Insulin Lispro in Patients with Type 1 Diabetes Using Multiple Daily Injections
    Garg, Satish K.
    McGill, Janet B.
    Rosenstock, Julio
    Hirsch, Irl B.
    Petrucci, Richard E.
    Chang, Ping-Chung
    Boss, Anders H.
    Richardson, Peter C.
    Skyler, Jay S.
    [J]. DIABETES, 2011, 60 : A250 - A250
  • [45] Twice-daily compared with once-daily insulin glargine in people with type 1 diabetes using meal-time insulin aspart
    Ashwell, SG
    Gebbie, J
    Home, PD
    [J]. DIABETES, 2005, 54 : A119 - A119
  • [46] Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart
    Ashwell, S. G.
    Gebbie, J.
    Home, P. D.
    [J]. DIABETIC MEDICINE, 2006, 23 (08) : 879 - 886
  • [47] Starting insulin therapy in type 2 diabetes: Twice-daily biphasic insulin aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride
    Kann, P. H.
    Wascher, T.
    Zackova, V.
    Moeller, J.
    Medding, J.
    Szocs, A.
    Mokan, M.
    Mrevlje, F.
    Regulski, M.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (09) : 527 - 532
  • [48] Comparison of twice-daily injection of biphasic insulin Lispro and basal-bolus therapy in insulin naive patients with type 2 diabetes
    Yamada, Satoru
    Masuda, Haruka
    Kitaoka, Akira
    Shiono, Kaoru
    Atsuda, Koichiro
    Irie, Junichiro
    Shimada, Akira
    [J]. DIABETES, 2007, 56 : A537 - A538
  • [49] Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine
    Rosenstock, Julio
    Eliaschewitz, Freddy G.
    Heilmann, Cory R.
    Muchmore, Douglas B.
    Hayes, Risa P.
    Belin, Ruth M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 : S63 - S73
  • [50] Switch from continuous subcutaneous insulin infusion (CSII) with insulin lispro [Humalog®]to multiple daily injections (MDI) with insulin glargine (Lantus) and insulin lispro
    Bode, B
    Schleusener, D
    Strange, P
    [J]. DIABETES, 2003, 52 : A102 - A103
12345